Analysts think CTXR stock price could increase by 1000%
May 10, 2025, 11:25 AM
15.95%
What does CTXR do
Citius Pharmaceuticals, based in Cranford, NJ, specializes in critical care products, particularly in oncology and anti-infectives. Its key products include LYMPHIR, Mino-Lok, Halo-Lido, Mino-Wrap, and NoveCite.
5 analysts think CTXR stock price will increase by 1000.32%. The current median analyst target is $8.16 compared to a current stock price of $0.74. The lowest analysts target is $4.04 and the highest analyst target is $9.45.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
